4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-25-211788
Chief Operating Officer sold 10,000 shares at $115.96 ($1,159,600)
- Chief Operating Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2025-09-22 | Option exercise 10b5-1 | +10,000 | $2.85 | $28,500 | 10,000 | D |
| Jacobson Mark L. Chief Operating Officer | 2025-09-22 | Sale 10b5-1 | −10,000 | $115.96 | $1,159,600 | 0 | D |
| Derivatives | |||||||
| Jacobson Mark L. Chief Operating Officer | 2025-09-22 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 35,378 | D | ||
| Open-market sales · 10,000 sh · avg $115.96 · $1,159,600 | |||||||
Loading xslF345X05/ownership.xml…